Celestica (CLS) director reports grant of 129 restricted share units

Rhea-AI Filing Summary

Celestica Inc. director reports grant of restricted share units

A director of Celestica Inc. (CLS) filed a Form 4 disclosing an equity award dated December 31, 2025. The reporting person received 129 restricted share units (RSUs), each representing a contingent right to receive one common share or an equivalent cash value at the holder's election.

According to the disclosure, one-third of the 129 RSUs vests annually over three years on the anniversary of the grant date. This filing reflects routine equity-based compensation for a board member rather than an open‑market purchase or sale of Celestica shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider CASCELLA ROBERT

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	129	$0.00	--

Holdings After Transaction: Restricted Share Units — 129 shares (Direct)

Footnotes (1)

1. Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election. On December 31, 2025, the reporting person was granted 129 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CASCELLA ROBERT

(Last) (First) (Middle)

5140 YONGE STREET

SUITE 1900

(Street)

TORONTO A6 M2N 6L7

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	12/31/2025		A		129		(2)	(2)	Common Shares	129	$0	129	D

Explanation of Responses:

1. Each restricted share unit ("RSU") represents a contingent right to receive one common share or an equivalent value in cash at the holder's election.

2. On December 31, 2025, the reporting person was granted 129 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date.

	/s/ Tracy Connelly McGilley, attorney-in-fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celestica Inc. (CLS) report in this Form 4?

A director of Celestica Inc. (CLS) reported receiving 129 restricted share units (RSUs) as of December 31, 2025 as part of equity compensation.

How many restricted share units were granted to the Celestica (CLS) director?

The director was granted 129 restricted share units (RSUs), as disclosed in the Form 4 filing.

How do the Celestica (CLS) director's RSUs vest?

The filing states that 1/3 of the 129 RSUs vests annually over three years on the anniversary of the December 31, 2025 grant date.

What does each RSU represent in the Celestica (CLS) Form 4 filing?

Each RSU represents a contingent right to receive one common share of Celestica Inc. or an equivalent value in cash at the holder's election.

Is the Celestica (CLS) Form 4 transaction a routine equity grant or a market trade?

The transaction is a grant of 129 RSUs to a director, which is a form of equity-based compensation, not an open-market purchase or sale of shares.

What is the relationship of the reporting person to Celestica Inc. (CLS)?

The reporting person is identified as a director of Celestica Inc. in the Form 4.